2022

Asia's Top Healthcare Leaders 50

Healthcare Leadership and Health-System Influence Watch

Edited and researched by InfluenceAsia Research and Editorial Desk. 2022 Annual Edition; built from the 2022 editorial window.

InfluenceAsia 50 Asia's Top Healthcare Leaders 2022 temporary banner placeholder

50Leaders Ranked

99.0Top Index Score

7Research Dimensions

14Markets

Ranking Introduction

Endemic Transition, Biotech Scale and Health-System Repair

InfluenceAsia 50: Asia's Top Healthcare Leaders 2022 identifies the executives, clinicians, scientists, public-health leaders and health-technology builders whose 2022 leadership became especially consequential to patient access, health-system resilience, vaccine supply, diagnostics, hospital transformation, biopharmaceutical innovation and digital care. The ranking is not a revenue table, hospital-size table or bibliometric tally; it evaluates leadership consequence, patient relevance, operating execution, scientific credibility and contribution to Asia's health systems in the 2022 context.

The 2022 healthcare cycle was defined by Omicron-era pressure, vaccination fatigue, reopening decisions, public-health communication, hospital recovery, digital-health normalization, biosimilar scale, oncology innovation, vaccine manufacturing, diagnostics capacity and the growing demand for affordable, trusted care. The most influential leaders combined science, institutional judgment and execution under conditions of social fatigue and operating complexity.

This is not a wealth list, hospital revenue table, traffic ranking or advertising award. It is an independent InfluenceAsia research and editorial ranking focused on healthcare consequence, institutional trust, access, innovation, public-health leadership and health-system influence.

The edition considers Asia-based and Asia-centered healthcare leaders active during the 2022 editorial window, including hospital founders, healthcare CEOs, biotech founders, pharmaceutical executives, vaccine scientists, diagnostics leaders, digital-health entrepreneurs, public-health administrators and clinical-science figures with material public-health or patient-care influence. Pure investors, symbolic owners, political figures without healthcare execution, and leaders without clear health-system relevance are excluded.

Health-System Lens

The healthcare leaders rebuilding trust, access and innovation.

Eligible Leaders

Who is considered for the 2022 edition.

Publication Use

Each entry includes leader, market, region, organization, 2022 role, primary healthcare field, score, 2022 contribution, influence territory, profile language and InfluenceAsia editorial rationale. The package is prepared for ranking pages, healthcare profiles, annual sector features, institutional tables and InfluenceAsia-branded web production.

Representative Leaders

Eight Leaders That Define The 2022 Health-System Thesis

#01

Adar Poonawalla

Chief Executive Officer

Organization: Serum Institute of India
Market: India
Index: 99.0

InfluenceAsia ranks Adar Poonawalla first for anchoring Asia's most important vaccine manufacturing platform.

#02

Kiran Mazumdar-Shaw

Executive Chairperson

Organization: Biocon Biologics
Market: India
Index: 98.4

InfluenceAsia ranks Kiran Mazumdar-Shaw for advancing affordable biologics at global scale from Asia.

#03

Christophe Weber

President and Chief Executive Officer

Organization: Takeda Pharmaceutical
Market: Japan
Index: 97.9

InfluenceAsia ranks Christophe Weber for sustaining Japan's strongest global biopharmaceutical platform.

#04

Haruo Naito

Chief Executive Officer

Organization: Eisai
Market: Japan
Index: 97.3

InfluenceAsia ranks Haruo Naito for leading Asia's most consequential 2022 neurology breakthrough.

#05

Zhong Nanshan

Respiratory scientist and public-health adviser

Organization: Chinese respiratory and public-health leadership
Market: China
Index: 96.7

InfluenceAsia ranks Zhong Nanshan for sustaining high-trust public-health leadership in China.

#06

Soumya Swaminathan

Chief Scientist and public-health leader

Organization: Global health science leadership
Market: India
Index: 96.2

InfluenceAsia ranks Soumya Swaminathan for elevating evidence-based healthcare leadership from Asia.

#07

Krishna Ella

Executive Chairman

Organization: Bharat Biotech
Market: India
Index: 95.6

InfluenceAsia ranks Krishna Ella for strengthening India's indigenous vaccine innovation platform.

#08

Chen Wei

Vaccine scientist

Organization: Military medical science and vaccine research
Market: China
Index: 95.0

InfluenceAsia ranks Chen Wei for advancing Asia's most visible 2022 mucosal vaccine innovation.

Full List

The Full List

50 leaders shown

No matching leaders found.

Rank	Leader	Platform	Market Base	Primary Sector	Index	Signal
1	Adar PoonawallaChief Executive Officer	Serum Institute of India	India	Vaccine manufacturing, global immunization and pandemic supply	99.0	Adar Poonawalla remained Asia's most consequential 2022 vaccine leader, guiding mass vaccine manufacturing, export resumption, booster supply and long-cycle immunization capacity after the acute emergency phase.
2	Kiran Mazumdar-ShawExecutive Chairperson	Biocon Biologics	India	Biosimilars, affordable biologics, diabetes, oncology and global biopharma	98.4	Kiran Mazumdar-Shaw became one of 2022's defining healthcare leaders through Biocon Biologics' transformative biosimilars expansion and her continued advocacy for affordable advanced medicines.
3	Christophe WeberPresident and Chief Executive Officer	Takeda Pharmaceutical	Japan	Global biopharmaceuticals, vaccines, rare disease, oncology and gastroenterology	97.9	Christophe Weber led Takeda in 2022 as Japan's largest global biopharmaceutical company advanced pipeline execution, vaccine work and patient-focused R&D transformation.
4	Haruo NaitoChief Executive Officer	Eisai	Japan	Neurology, dementia care, oncology and human health care strategy	97.3	Haruo Naito became one of Asia's most important 2022 healthcare leaders as Eisai's Alzheimer's program delivered landmark late-stage evidence and changed expectations for dementia treatment.
5	Zhong NanshanRespiratory scientist and public-health adviser	Chinese respiratory and public-health leadership	China	Respiratory medicine, infectious disease, pandemic policy and public communication	96.7	Zhong Nanshan remained a central 2022 healthcare authority in China, shaping public understanding of respiratory risk, vaccination, severe-disease prevention and pandemic-transition choices.
6	Soumya SwaminathanChief Scientist and public-health leader	Global health science leadership	India	Evidence-based policy, vaccine equity, research translation and global health communication	96.2	Soumya Swaminathan remained one of Asia's most influential 2022 health-science leaders through evidence-based pandemic communication, vaccine equity advocacy and research-to-policy translation.
7	Krishna EllaExecutive Chairman	Bharat Biotech	India	Vaccines, indigenous biotechnology, infectious disease and public-health innovation	95.6	Krishna Ella remained a major 2022 healthcare leader as Bharat Biotech carried forward indigenous vaccine innovation and broader infectious-disease product development.
8	Chen WeiVaccine scientist	Military medical science and vaccine research	China	Aerosolized vaccines, infectious disease, immunology and emergency medicine	95.0	Chen Wei became one of 2022's most important vaccine scientists in Asia as aerosolized COVID-19 vaccine work moved from research promise toward practical booster use.
9	George GaoVirologist and public-health administrator	National disease-control leadership	China	Disease surveillance, immunology, virology and pandemic response	94.4	George Gao remained a major 2022 healthcare figure through disease-control leadership, vaccine-science commentary and institutional transition after years of pandemic command.
10	Dr. Prathap C. ReddyFounder and Chairman	Apollo Hospitals	India	Hospital systems, integrated care, digital health and medical access	93.9	Dr. Prathap C. Reddy remained a defining 2022 hospital leader through Apollo's integrated care ecosystem, hospital network, pharmacy reach and digital-health expansion.
11	Dr. Devi ShettyFounder and Chairman	Narayana Health	India	Affordable tertiary care, cardiac surgery, hospital systems and health access	93.3	Dr. Devi Shetty remained one of Asia's most respected 2022 healthcare leaders through affordable tertiary care, cardiac excellence and a continuing push to reduce the cost of complex treatment.
12	Dr. Sangita ReddyJoint Managing Director	Apollo Hospitals	India	Digital health, hospital transformation, preventive care and healthcare technology	92.7	Dr. Sangita Reddy strengthened Apollo's 2022 digital-health and integrated-care agenda through telemedicine, health records, remote care and patient-centered platforms.
13	John RimPresident and Chief Executive Officer	Samsung Biologics	South Korea	Biologics manufacturing, CDMO services and biopharmaceutical infrastructure	92.2	John Rim led Samsung Biologics in 2022 through major biologics manufacturing expansion, capacity planning and global contract-development discipline.
14	Ge LiFounder, Chairman and Chief Executive Officer	WuXi AppTec	China	Drug discovery, development services, manufacturing and life-sciences infrastructure	91.6	Ge Li remained one of Asia's most consequential 2022 life-sciences leaders through integrated discovery, development and manufacturing services supporting global pharmaceutical innovation.
15	John OylerCo-founder, Chairman and Chief Executive Officer	BeiGene	China / Global	Oncology, hematology, global clinical development and innovative medicines	91.0	John Oyler strengthened BeiGene's 2022 oncology position through rapid product growth, global clinical operations and an ambition to make innovative cancer medicines more broadly accessible.
16	Yin WeidongChairman, President and Chief Executive Officer	Sinovac	China	Vaccines, immunization, infectious disease and global vaccine supply	90.5	Yin Weidong remained a significant 2022 vaccine leader through Sinovac's global vaccine supply, non-COVID vaccine expansion and continued immunization manufacturing work.
17	Yu XuefengChairman and Chief Executive Officer	CanSino Biologics	China	Vaccine technology, viral vectors, inhaled vaccines and infectious disease	89.9	Yu Xuefeng became a notable 2022 healthcare leader as CanSino's inhaled vaccine booster marked a major step in China's vaccine-technology diversification.
18	Sunao ManabePresident and Chief Executive Officer	Daiichi Sankyo	Japan	Oncology, antibody-drug conjugates, cardiovascular medicine and global pharma	89.3	Sunao Manabe led Daiichi Sankyo in 2022 as antibody-drug conjugate momentum elevated Japan's role in global oncology innovation.
19	Dilip ShanghviFounder and Managing Director	Sun Pharmaceutical Industries	India	Specialty pharma, generics, dermatology, ophthalmology and global medicine access	88.7	Dilip Shanghvi sustained Sun Pharma's 2022 leadership across specialty pharmaceuticals, generics and global medicine access while strengthening India's presence in complex regulated markets.
20	Umang VohraManaging Director and Global Chief Executive Officer	Cipla	India	Respiratory medicine, generics, HIV care, access and global pharma	88.2	Umang Vohra remained a major 2022 healthcare leader through Cipla's respiratory franchise, access-oriented medicines and global generics execution.
21	Satish ReddyChairman	Dr. Reddy's Laboratories	India	Generics, active ingredients, branded medicines and pharmaceutical access	87.6	Satish Reddy sustained Dr. Reddy's 2022 role in affordable medicines, generics, APIs and specialty development across India and global markets.
22	Pankaj PatelChairman	Zydus Lifesciences	India	Vaccines, generics, specialty medicines and Indian life sciences	87.0	Pankaj Patel remained a significant 2022 healthcare leader through Zydus Lifesciences' vaccine experience, pharmaceutical breadth and innovation-linked Indian life-sciences platform.
23	Zhang WenhongInfectious-disease physician and public-health communicator	Shanghai infectious-disease leadership	China	Infectious disease, clinical guidance, COVID communication and hospital medicine	86.5	Zhang Wenhong remained one of China's most important 2022 clinical voices through infectious-disease guidance, public communication and medical interpretation during Omicron pressure.
24	Chris ChenChief Executive Officer	WuXi Biologics	China / Hong Kong	Biologics discovery, development, manufacturing and CDMO services	85.9	Chris Chen led WuXi Biologics through 2022 as the company expanded its integrated biologics platform and supported global clients across development and manufacturing.
25	Michael YuFounder, Chairman and Chief Executive Officer	Innovent Biologics	China	Oncology biologics, immunology, metabolic disease and innovative medicines	85.3	Michael Yu advanced Innovent's 2022 position in oncology and biologics through product commercialization, pipeline development and affordability-oriented innovation.
26	Wu YifangChairman and Chief Executive Officer	Fosun Pharma	China	Pharmaceuticals, vaccines, medical devices, diagnostics and healthcare services	84.8	Wu Yifang led Fosun Pharma's 2022 healthcare platform across medicines, vaccines, diagnostics, medical devices and healthcare services amid complex pandemic and market conditions.
27	Jiang RenshengChairman	Zhifei Biological	China	Vaccines, immunization and infectious disease prevention	84.2	Jiang Rensheng remained a major 2022 Chinese healthcare leader through vaccine distribution, immunization programs and continued participation in infectious-disease prevention.
28	Liu JingzhenChairman	Sinopharm	China	Pharmaceutical distribution, vaccines, medicines and national healthcare supply	83.6	Liu Jingzhen remained a significant 2022 healthcare leader through Sinopharm's vaccine, medicine-distribution and national healthcare-supply role.
29	Prashant TandonCo-founder and Chief Executive Officer	Tata 1mg	India	Digital pharmacy, diagnostics, telehealth and consumer health platforms	83.0	Prashant Tandon remained a major 2022 digital-health leader as Tata 1mg strengthened the link between e-pharmacy, diagnostics, online consultation and trusted consumer healthcare.
30	Jonathan SudhartaFounder and Chief Executive Officer	Halodoc	Indonesia	Telehealth, digital pharmacy, diagnostics and healthcare access	82.5	Jonathan Sudharta remained one of Southeast Asia's most important 2022 healthtech leaders through Halodoc's role in telemedicine, pharmacy access, diagnostics and Indonesian healthcare convenience.
31	Lim Wai MunFounder and Chief Executive Officer	Doctor Anywhere	Singapore	Telemedicine, digital clinics, regional primary care and consumer health	81.9	Lim Wai Mun became one of Singapore's most visible 2022 healthcare entrepreneurs through Doctor Anywhere's regional digital-clinic model and Southeast Asian expansion.
32	Dr. Azad MoopenFounder Chairman and Managing Director	Aster DM Healthcare	India / United Arab Emirates	Hospitals, clinics, pharmacies, primary care and regional healthcare delivery	81.3	Dr. Azad Moopen sustained Aster DM Healthcare's 2022 role across India and the Gulf, combining hospitals, clinics, pharmacies and affordable care delivery.
33	Dr. Shamsheer VayalilFounder and Chairman	Burjeel Holdings	United Arab Emirates / India	Hospitals, specialty care, UAE private healthcare and regional provider networks	80.8	Dr. Shamsheer Vayalil became a major 2022 Gulf healthcare leader as Burjeel Holdings consolidated its platform and entered public-market life during a period of regional healthcare expansion.
34	Faisal Al NassarChief executive leader	Dr. Sulaiman Al Habib Medical Services Group	Saudi Arabia	Hospitals, digital systems, specialty care and Saudi healthcare delivery	80.2	Faisal Al Nassar represented Saudi Arabia's 2022 healthcare-provider leadership through HMG's expansion, operational discipline and specialty-care platform.
35	Abhay SoiChairman and Managing Director	Max Healthcare	India	Hospital operations, tertiary care, provider consolidation and healthcare efficiency	79.6	Abhay Soi led Max Healthcare through 2022 as one of India's strongest hospital operators, emphasizing efficiency, specialty care and disciplined expansion.
36	Dr. Naresh TrehanFounder, Chairman and Managing Director	Medanta	India	Multi-specialty hospitals, cardiac care, tertiary medicine and clinical excellence	79.0	Dr. Naresh Trehan remained a major 2022 healthcare leader through Medanta's tertiary-care model, cardiac reputation and high-acuity hospital expansion.
37	Ameera ShahManaging Director	Metropolis Healthcare	India	Diagnostics, pathology, preventive testing and women-led healthcare leadership	78.5	Ameera Shah remained an important 2022 diagnostics leader as Metropolis adapted from pandemic testing demand toward broader preventive, pathology and consumer diagnostics.
38	Shashank NDFounder and Chief Executive Officer	Practo	India	Digital health, doctor discovery, teleconsultation and practice management	77.9	Shashank ND remained a significant 2022 digital-health leader through Practo's patient-provider discovery, teleconsultation and clinic-technology ecosystem.
39	Kenneth MakDirector of Medical Services	Singapore medical and public-health leadership	Singapore	Public health, diagnostics, clinical governance and healthcare policy	77.3	Kenneth Mak remained a central 2022 healthcare leader in Singapore through endemic-transition guidance, diagnostics policy, clinical governance and public-health communication.
40	Noor Hisham AbdullahDirector-General of Health	Malaysia health administration	Malaysia	Public health, pandemic management, surgery and health-system trust	76.8	Noor Hisham Abdullah remained one of Southeast Asia's most respected 2022 public-health leaders through Malaysia's pandemic management and transition planning.
41	Gabriel LeungPublic-health professor and institutional leader	Hong Kong public-health and medical-academic leadership	Hong Kong	Epidemiology, health systems, medical education and community health	76.2	Gabriel Leung remained a major 2022 healthcare leader through epidemiological judgment, medical education leadership and the transition from academic health leadership into broader community impact.
42	Kwok-Yung YuenClinical microbiologist and infectious-disease expert	Hong Kong clinical microbiology leadership	Hong Kong	Clinical microbiology, virology, infection control and hospital safety	75.6	Kwok-Yung Yuen remained one of Asia's most influential 2022 infectious-disease clinicians through hospital infection-control expertise, virology and public-health guidance in Hong Kong.
43	Ahn Jae-yongChief Executive Officer	SK bioscience	South Korea	Vaccines, biologics, COVID-19 vaccine development and manufacturing	75.1	Ahn Jae-yong became a notable 2022 healthcare leader as SK bioscience advanced Korea's first domestically developed COVID-19 vaccine and expanded vaccine-platform credibility.
44	Seo Jung-jinFounder and honorary chairman	Celltrion	South Korea	Biosimilars, biologics, antibodies and affordable advanced medicine	74.5	Seo Jung-jin remained a defining Korean healthcare figure in 2022 through Celltrion's biosimilar platform and broader contribution to affordable biologic medicine.
45	Samantha DuFounder, Chairperson and Chief Executive Officer	Zai Lab	China	Innovative medicines, oncology, autoimmune disease and women's healthcare leadership	73.9	Samantha Du remained an important 2022 healthcare leader through Zai Lab's innovative-medicine portfolio, global partnerships and women-led biotech leadership in China.
46	Ying HuangChief Executive Officer	Legend Biotech	China / Global	Cell therapy, oncology, CAR-T and translational biotechnology	73.3	Ying Huang became a significant 2022 healthcare leader as Legend Biotech's cell-therapy work reached a landmark commercial milestone in multiple myeloma treatment.
47	Ranjan PaiChairman	Manipal Hospitals	India	Hospital networks, medical education, tertiary care and provider expansion	72.8	Ranjan Pai remained a significant 2022 healthcare leader through Manipal's hospital network, medical-education heritage and role in India's consolidating provider landscape.
48	Paolo BorromeoPresident and Chief Executive Officer	AC Health	Philippines	Primary care, pharmacies, clinics, hospitals and digital health	72.2	Paolo Borromeo remained a key 2022 Philippine healthcare leader through AC Health's integrated model across clinics, pharmacies, hospitals and digital health.
49	Dr. K. Srinath ReddyPublic-health physician and institution builder	Public health and cardiovascular-health leadership	India	Public health, cardiovascular disease, health policy and prevention	71.6	Dr. K. Srinath Reddy remained a major 2022 Asian healthcare leader through public-health institution-building, prevention advocacy and health-policy thought leadership.
50	Dr. Randeep GuleriaPulmonologist and medical institution leader	Indian clinical and pulmonary-medicine leadership	India	Pulmonary medicine, critical care, clinical communication and pandemic response	71.1	Dr. Randeep Guleria remained a prominent 2022 healthcare leader through pulmonary expertise, clinical communication and institutional leadership during India's pandemic recovery phase.

Methodology

How InfluenceAsia Built The Ranking

Healthcare Leader Universe Formation

InfluenceAsia formed a 2022 universe of Asia-based and Asia-centered healthcare leaders across hospitals, public health, pharmaceuticals, biotechnology, vaccines, diagnostics, digital health, health systems and medical science.

Eligibility Review

Candidates were reviewed for material healthcare activity during the 2022 editorial window, clear leadership responsibility, patient or public-health relevance, field impact and contribution to Asian health systems. Pure investors, political figures without healthcare execution, symbolic owners and leaders without clear health relevance were removed.

Influence Scoring

Each eligible leader was assessed across seven weighted dimensions: 2022 healthcare contribution, patient access and public-health impact, innovation, operating scale, institutional credibility, Asia relevance and strategic durability.

2022 Perspective Control

The list is written as a 2022 annual edition. InfluenceAsia does not use later approvals, future role changes, subsequent controversies, later clinical outcomes or later market reversals to rewrite the influence profile visible in 2022.

Research Dimension	Weight	Definition
2022 Healthcare Contribution	24%	The leader's visible contribution during the 2022 annual window, including vaccine supply, patient access, public-health guidance, hospital delivery, medicine availability, diagnostics, digital care and system resilience.
Patient Access and Public-Health Impact	18%	The extent to which the leader improved access, affordability, safety, trust, prevention, treatment pathways, frontline capacity or population-level health protection.
Scientific, Clinical and Technological Innovation	16%	The leader's role in advancing vaccines, biologics, biosimilars, oncology, diagnostics, digital health, telemedicine, data systems, clinical protocols or biomedical manufacturing.
Scale and Operating Execution	14%	The ability to deliver healthcare at meaningful scale through hospitals, manufacturing networks, laboratories, digital platforms, clinical teams, supply chains or public-health systems.
Institutional Credibility and Trust	12%	Governance, medical reputation, scientific credibility, regulatory discipline, public communication, quality culture and reliability under 2022 operating pressure.
Asia Relevance	10%	The importance of the leader's work to Asian patients, families, clinicians, health workers, public agencies, payers, biotech ecosystems, hospitals and regional health security.
Strategic Durability	6%	The strength of the leader's 2022 platform as a foundation for continued health-system relevance beyond the annual window.

Copyright, Data Notes and Editorial Disclaimer

Copyright Notice

Copyright 2022 InfluenceAsia. All rights reserved. InfluenceAsia 50: Asia's Top Healthcare Leaders 2022, including the ranking structure, scoring presentation, methodology language, leader profiles and editorial rationales, is prepared as an original InfluenceAsia editorial and research work.

Original Research Statement

The ranking is independently selected, organized, written and presented by InfluenceAsia for editorial publication. No inclusion, rank position, score or profile text should be read as paid placement, sponsored recognition, nomination, certification, clinical endorsement or medical validation.

Independence Statement

Inclusion in InfluenceAsia 50: Asia's Top Healthcare Leaders 2022 does not imply sponsorship, endorsement, partnership, approval, data submission, nomination, payment or participation by any leader, company, hospital, regulator, university, laboratory, foundation, patient group, professional body or government agency.

Editorial Nature

The ranking is an editorial and research product. It is not medical advice, legal advice, tax advice, investment advice, clinical guidance, quality certification, regulatory review, product approval, drug-safety assessment, hospital accreditation, professional credentialing or a recommendation to diagnose, treat, prescribe, buy, sell, fund, employ, appoint, partner with or rely on any person or organization.

Leader and Institution Accuracy

Leader names, markets, organizations, roles, fields and descriptions are presented within the 2022 editorial window and should be checked before republication where titles, responsibilities, product status, regulatory status, clinical data, institutional names, leadership positions or corporate structures may change.

Healthcare Risk Disclaimer

Healthcare impact is complex and may be affected by clinical evidence, regulatory review, delivery quality, patient safety, local context, ethics, manufacturing reliability, implementation risk and health-system capacity. InfluenceAsia's inclusion of a leader recognizes 2022 editorial influence and does not certify effectiveness, safety, ethics, compliance, financial stewardship, clinical outcomes or future performance.

Reuse Terms

The dataset may be used to prepare InfluenceAsia-branded ranking pages, annual features, healthcare profiles, institutional tables and structured web content, provided the InfluenceAsia ranking identity, 2022 publication perspective and editorial integrity are preserved.